Takeda Pharmaceutical Non-GAAP EPS of ¥279.00, revenue of ¥2219.5B; updates FY outlook

**Takeda Pharmaceutical Company Limited Reports 1H Financial Results**

*October 30, 2025 | 3:17 AM ET*

Takeda Pharmaceutical Company Limited announced its financial results for the first half of the fiscal year. The company reported a Non-GAAP Earnings Per Share (EPS) of ¥279.00.

Revenue for the period totaled ¥2,219.5 billion, reflecting a year-over-year decrease of 6.9%.

Stay tuned for more updates and trending news in the pharmaceutical industry.
https://seekingalpha.com/news/4511033-takeda-pharmaceutical-non-gaap-eps-of-27900-revenue-of-22195b-updates-fy-outlook?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news

Leave a Reply

Your email address will not be published. Required fields are marked *